March 28, 2025

FDA Approves Perioperative Durvalumab Plus Chemo for Muscle-Invasive Bladder Cancer – OncLive

March 22, 2025

Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning – Nature

March 22, 2025

Deep learning on T2WI to predict the muscle-invasive bladder cancer: a multi-center clinical study – Nature

March 11, 2025

Genomic Characterization of Young-Onset Bladder Cancer – Alina Basnet – UroToday

March 10, 2025

Urinary Microbiome and Bladder Cancer: Can Bacteria Predict Recurrence? – NewYork-Presbyterian